![Ronit Bakimer-Kleiner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Ronit Bakimer-Kleiner served as the Chief Development Officer at Cellect Biotechnology Ltd.
from 2017 to 2019.
Prior to this, he obtained an undergraduate degree from Tel-Aviv University and graduate and doctorate degrees from Ben-Gurion University of the Negev.
Anciens postes connus de Ronit Bakimer-Kleiner
Sociétés | Poste | Fin |
---|---|---|
QUOIN PHARMACEUTICALS, LTD. | Corporate Officer/Principal | 03/08/2019 |
Formation de Ronit Bakimer-Kleiner
Tel-Aviv University | Undergraduate Degree |
Ben-Gurion University of the Negev | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Cellect Biotechnology Ltd.
![]() Cellect Biotechnology Ltd. Medical SpecialtiesHealth Technology Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel. | Health Technology |